Bard Associates Inc Harrow Health, Inc. Transaction History
Bard Associates Inc
- $262 Million
- Q1 2024
A detailed history of Bard Associates Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Bard Associates Inc holds 69,880 shares of HROW stock, worth $1.46 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
69,880
Previous 66,050
5.8%
Holding current value
$1.46 Million
Previous $739,000
25.03%
% of portfolio
0.35%
Previous 0.29%
Shares
14 transactions
Others Institutions Holding HROW
# of Institutions
123Shares Held
21.3MCall Options Held
113KPut Options Held
366K-
Opaleye Management Inc. Boston, MA3.92MShares$81.9 Million12.62% of portfolio
-
Private Capital Management, LLC Naples, FL3.01MShares$62.9 Million4.93% of portfolio
-
Black Rock Inc. New York, NY2.18MShares$45.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$38.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY953KShares$19.9 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $565M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...